These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16673354)

  • 1. Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis.
    Atkin G; Taylor NJ; Daley FM; Stirling JJ; Richman P; Glynne-Jones R; d'Arcy JA; Collins DJ; Padhani AR
    Br J Surg; 2006 Aug; 93(8):992-1000. PubMed ID: 16673354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis.
    Zhang XM; Yu D; Zhang HL; Dai Y; Bi D; Liu Z; Prince MR; Li C
    J Magn Reson Imaging; 2008 Jun; 27(6):1309-16. PubMed ID: 18504761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer.
    Su MY; Cheung YC; Fruehauf JP; Yu H; Nalcioglu O; Mechetner E; Kyshtoobayeva A; Chen SC; Hsueh S; McLaren CE; Wan YL
    J Magn Reson Imaging; 2003 Oct; 18(4):467-77. PubMed ID: 14508784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer.
    de Lussanet QG; Backes WH; Griffioen AW; Padhani AR; Baeten CI; van Baardwijk A; Lambin P; Beets GL; van Engelshoven JM; Beets-Tan RG
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1309-15. PubMed ID: 16125874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Gd-DTPA enhanced MRI as a surrogate marker of angiogenesis in tissue-engineered bladder constructs: a feasibility study in rabbits.
    Cheng HL; Chen J; Babyn PS; Farhat WA
    J Magn Reson Imaging; 2005 Apr; 21(4):415-23. PubMed ID: 15778952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.
    Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Zuna I; Knof A; Brix G; Schaeffer U; Wilkens C; Schoenberg SO; Essig M; Vaupel P; van Kaick G
    Cancer Res; 1997 Nov; 57(21):4777-86. PubMed ID: 9354439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis.
    Ren J; Huan Y; Wang H; Chang YJ; Zhao HT; Ge YL; Liu Y; Yang Y
    Clin Radiol; 2008 Feb; 63(2):153-9. PubMed ID: 18194690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive imaging surrogate of angiogenesis in osteosarcoma.
    Bajpai J; Gamanagatti S; Sharma MC; Kumar R; Vishnubhatla S; Khan SA; Rastogi S; Malhotra A; Bakhshi S
    Pediatr Blood Cancer; 2010 Apr; 54(4):526-31. PubMed ID: 19890899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer.
    George ML; Dzik-Jurasz AS; Padhani AR; Brown G; Tait DM; Eccles SA; Swift RI
    Br J Surg; 2001 Dec; 88(12):1628-36. PubMed ID: 11736977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal cancer: dynamic contrast-enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression.
    Lollert A; Junginger T; Schimanski CC; Biesterfeld S; Gockel I; Düber C; Oberholzer K
    J Magn Reson Imaging; 2014 Jun; 39(6):1436-42. PubMed ID: 24127411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome.
    Hawighorst H; Weikel W; Knapstein PG; Knopp MV; Zuna I; Schönberg SO; Vaupel P; van Kaick G
    Clin Cancer Res; 1998 Oct; 4(10):2305-12. PubMed ID: 9796959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 (MMP-9) expression in brain tuberculomas.
    Haris M; Husain N; Singh A; Awasthi R; Singh Rathore RK; Husain M; Gupta RK
    J Magn Reson Imaging; 2008 Sep; 28(3):588-97. PubMed ID: 18777539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies.
    Morgan B; Thomas AL; Drevs J; Hennig J; Buchert M; Jivan A; Horsfield MA; Mross K; Ball HA; Lee L; Mietlowski W; Fuxuis S; Unger C; O'Byrne K; Henry A; Cherryman GR; Laurent D; Dugan M; Marmé D; Steward WP
    J Clin Oncol; 2003 Nov; 21(21):3955-64. PubMed ID: 14517187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: correlation with microvascular density and vascular endothelial growth factor expression.
    Kim YE; Lim JS; Choi J; Kim D; Myoung S; Kim MJ; Kim KW
    Korean J Radiol; 2013; 14(6):878-85. PubMed ID: 24265562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
    Cheng HL; Wallis C; Shou Z; Farhat WA
    J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
    Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
    J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
    Rosen MA; Schnall MD
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.